Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Ted Jenkins - Vice President, Head of Investor Relations Ankit Mahadevia - Chief Executive Officer David Melnick - Chief Medical Officer Cristina Larkin - Chief Operating Officer Sath Shukla - Chief Financial Officer Conference Call Participants Ritu Baral - Cowen Louise Chen - Cantor Fitzgerald & Co. Ram Selvaraju - H.C. Wainwright Esther Hong - Berenberg Operator Good afternoon, and we ...